Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma
Public ClinicalTrials.gov record NCT00186888. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Protocol for the Study and Treatment of Patients With Intraocular Retinoblastoma
Study identification
- NCT ID
- NCT00186888
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- St. Jude Children's Research Hospital
- Other
- Enrollment
- 107 participants
Conditions and interventions
Conditions
Interventions
- Enucleation Procedure
- External Beam Radiation Radiation
- Focal Therapies Procedure
- G-CSF Other
- Periocular carboplatin Procedure
- Vincristine + Carboplatin + Etoposide Drug
- Vincristine and Topotecan Drug
- Vincristine, Carboplatin Drug
- Vincristine, Carboplatin and Etoposide Drug
- vincristine, cyclophosphamide, and doxorubicin Drug
Procedure · Radiation · Other + 1 more
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 6, 2005
- Primary completion
- Oct 31, 2013
- Completion
- Nov 11, 2024
- Last update posted
- Sep 3, 2025
2005 – 2024
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| St. Jude Children's Research Hospital | Memphis | Tennessee | 38105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00186888, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 3, 2025 · Synced May 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00186888 live on ClinicalTrials.gov.